Publications
Navigate forward to interact with the calendar and select a date. Press the question mark key to get the keyboard shortcuts for changing dates.
Navigate backward to interact with the calendar and select a date. Press the question mark key to get the keyboard shortcuts for changing dates.
February 25, 2025|Knowledge Base Articles
To Do: Pass the EPIC Act for Small-Molecule Drugs
Congress should pass the Ensuring Pathways to Innovative Cures (EPIC) Act to give small-molecule drugs the same 13-year market time before price setting as biologics.
February 25, 2025|Reports & Briefings
The Inflation Reduction Act Is Negotiating the United States Out of Drug Innovation
The Inflation Reduction Act (IRA) undermines innovation in small-molecule drugs by subjecting them to price controls after 9 years, whereas large-molecule drugs (biologics) are allowed 13 years of market pricing. Congress should pass the bipartisan EPIC Act to remedy this issue.
February 25, 2025|Testimonies & Filings
Comments to the UK Government on Proposed Changes to the Copyright, Design, and Patents Act 1988
The Center for Data Innovation submitted these comments to the UK government’s Intellectual Property Office, Department for Science, Innovation and Technology, and Department for Culture, Media and Sport on its consultation on proposed changes to the UK’s copyright regime, the Copyright, Design, and Patents Act (CDPA) 1988.
February 25, 2025|Blogs
What Vance Left Unsaid in Paris: America’s AI Leadership Hinges on Big Tech Leadership
Vice President Vance was right to warn against stifling AI innovation with excessive regulation, but the Trump administration must go further by pushing back against policies like the EU’s Digital Markets Act and similar U.S. regulatory efforts that undermine American tech leadership. To maintain global competitiveness, the U.S. should support its leading tech companies, ensuring they have the scale and capital needed to drive AI and technological advancements, rather than subjecting them to restrictive regulations that benefit foreign competitors.
February 24, 2025|Blogs
The Merger Guidelines Memoranda: An Opening Blunder by the Trump Administration
The possibility of a new bipartisan consensus based on the Biden administration’s failed merger policies should concern Senate Republicans.
February 24, 2025|Podcasts
Podcast: The Winds of War, With Susan C. Schwab and Rob Atkinson
In the inaugural episode of ITIF's Trade War Podcast, host Stan McCoy discusses recent developments and challenges in global trade policy with Ambassador Susan C. Schwab and Rob Atkinson.
February 22, 2025|Op-Eds & Contributed Articles
How to Close Loopholes on Chinese E-Commerce and Boost US Retailers
A well-calibrated approach that prevents Chinese companies like Shein and Temu from exploiting loopholes while incentivizing compliance and supporting vetted sellers on U.S. platforms would best serve U.S. economic and strategic interests.
February 21, 2025|Op-Eds & Contributed Articles
Broadband Policies Are Wasting the Chance to Make America Connected
The United States has spent decades and billions of dollars to achieve universal broadband access. Yet the digital divide continues because many Americans still face barriers to affordability or lag in digital literacy. It’s time for a bold rethinking of broadband policy to match today’s realities.
February 21, 2025|Testimonies & Filings
Comments to the California Privacy Protection Agency’s Proposed AI Regulations
The California Privacy Protection Agency (CPPA) has proposed regulations that would impose new requirements on businesses using automated decision-making technology.
February 21, 2025|Blogs
Intermediate Goods: The Hidden Cost of Blanket Tariffs
Imposing blanket tariffs on our allies will only weaken American industries. If Trump wants to bring back U.S. manufacturing, placing targeted tariffs on specific Chinese goods is the way to do it.